| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.23 | 9e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |